UCFA
TXMD icon

United Capital Financial Advisors’s TherapeuticsMD TXMD Stock Holding History

United Capital Financial Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-220
Closed -$33K – 743
2013
Q2 		$33K Buy
+220
New +$30.1K ﹤0.01% 694

Other funds holding TXMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

United Capital Financial Advisors's TXMD Position: Q3 2013 in Review

United Capital Financial Advisors sold out of TherapeuticsMD (TXMD) in Q3 2013, closing a stake of 220 shares — an estimated $33K sold.

United Capital Financial Advisors first reported a position in TXMD in Q2 2013 and held it in 1 quarter. The position peaked at $33K in Q2 2013. 53 funds tracked by Wall St. Rank hold TXMD as of Q3 2013.

  • United Capital Financial Advisors reported no remaining TherapeuticsMD position as of Q3 2013 after selling out during the quarter.
  • United Capital Financial Advisors sold 220 TherapeuticsMD shares in Q3 2013, an estimated $33K.
  • United Capital Financial Advisors first reported a position in TherapeuticsMD in Q2 2013 and held it in 1 quarter.
  • United Capital Financial Advisors's TherapeuticsMD position peaked at $33K in Q2 2013.
  • 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2013.

Based on United Capital Financial Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.